Form 8-K - Current report:
SEC Accession No. 0001193125-25-028050
Filing Date
2025-02-18
Accepted
2025-02-18 06:19:13
Documents
15
Period of Report
2025-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d897036d8k.htm   iXBRL 8-K 41797
2 EX-99.1 d897036dex991.htm EX-99.1 13032
6 GRAPHIC g897036g0213091511646.jpg GRAPHIC 3587
  Complete submission text file 0001193125-25-028050.txt   191324

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20250217.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20250217_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20250217_pre.xml EX-101.PRE 11265
17 EXTRACTED XBRL INSTANCE DOCUMENT d897036d8k_htm.xml XML 3629
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 883099146 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 25632584
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)